Ephraim Brener

Title: Ephraim Brener: Innovator in Pharmaceutical Compositions

Introduction

Ephraim Brener is a notable inventor based in Rishon Lezion, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance antimicrobial efficacy. With a total of four patents to his name, Brener's work is at the forefront of innovative medical solutions.

Latest Patents

Brener's latest patents include groundbreaking inventions such as "Compositions and methods of potentiating antimicrobials." This patent discloses pharmaceutical compositions that combine at least one antibacterial agent with at least one cannabinoid, aimed at treating or preventing bacterial infections or biofilms in subjects in need. Another significant patent is "Combination of cannabinoids and n-acylethanolamines," which provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, along with methods for their use in preventing and treating various conditions that can be addressed with cannabinoid therapies.

Career Highlights

Ephraim Brener has established himself as a key figure in the pharmaceutical industry. His innovative approaches to combining cannabinoids with traditional treatments have opened new avenues for research and application in medical science. His work is characterized by a commitment to improving patient outcomes through novel therapeutic strategies.

Collaborations

Brener collaborates with esteemed colleagues such as Ascher Shmulewitz and Elran Haber. Their combined expertise enhances the potential impact of their research and development efforts in the pharmaceutical sector.

Conclusion

Ephraim Brener's contributions to pharmaceutical innovations demonstrate his dedication to advancing medical science. His patents reflect a forward-thinking approach that integrates cannabinoids into traditional treatments, paving the way for new therapeutic possibilities.